This website uses cookies. By using our website you consent to all cookies in accordance with our Privacy Policy. Read more - OK, thanks

Suggested Publications

Cumulative vaccine and non–vaccine targeted infections
This week WAidid suggests an article just published on the Journal of the American Medical Association and titled "Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non–Vaccine Targeted In...
Infliximab+IVIG VS IVIG alone as initial therapy in children with KD
The article we suggest this week "Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children with Kawasaki Disease Presenting with Coronary Artery Lesions: Is Dual Therapy More Effective?"  has been publis...
Human Neonatal Rotavirus Vaccine (RV3-BB)
WAidid suggests this week an article publisched last month on NEJM and entitled "Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth"
SUMMARY:Despite evidence of the success of rotavirus vaccines, more than 90 million infants st...
H-pylori cagA+ and milder duodenal histological changes
This week we suggest an article published in August 2017 on Frontiers in cellular and infection microbiology, Helicobacter pylori cagA+ is associated with milder duodenal histological changes in Chilean celiac patients. You can find the full art...
MDR-TB and beyond: current evidence on bedaquiline
The article we suggest this week,"Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline", has been published recently on the European Respiratory Journal.
AUTHORS: Emanuele Pontali, Lia D&r...
Rotavirus Vaccines: success and challenges
This week we suggestan article authored by Professor Miguel O'Ryan, WAidid board member, Rotavirus Vaccines: a story of success with challenges ahead, published in August 2017. You can find the full article here.
Several decades of epidemiologi...
Vaccines to Prevent Ebola in Liberia
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
The Ebola virus disease (EVD) outbreak, that began in December 2013 in western Africa, created new challenges for the design and implementation of protocols to test experim...
Antibacterial agents in clinical developement
World Health Organization. Antibacterial agents in clinical developement. An analysis of the antibacterial clinical development pipeline, including tuberculosis
The report shows a serious lack of new antibiotics under development to combat the growi...
Mannose-binding lectin and toll-like receptors and the risk of respiratory infections and AOM in children
Polymorphisms of Mannose-binding Lectin and Toll-like Receptors 2, 3, 4, 7 and 8 and the Risk of Respiratory Infections and Acute Otitis Media in Children
Acute respiratory infections (RI) are the most common of all illnesses, mainly caused by rhino...
WHO - Multidisease testing devices in integrated laboratory networks
Considerations for adoption and use of multidisease testing devices in integrated laboratory networks (TB, HIV and hepatitis)
SUMMARY:Several new laboratory technologies are available or are being developed to allow for testing of different conditio...
Chest radiography in tb detection (WHO)
WHO. Chest radiography in tuberculosis detection – Summary of current WHO recommendations and guidance on programmatic approaches
The document is a consolidated summary of WHO recommendations on the use chest radiography (CXR) in TB detection ...
Antibiotics for Smaller Skin Abscesses
This week WAidid suggests the article A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses, recently published on the NEJM.
SUMMARYUncomplicated skin abscesses are common. Staphylococcus aureus (S. aureus), including methicillin...
XDR-TB regimens
- Tadolini M, Lingtsang RD, Tiberi S, Enwerem M, D'Ambrosio L, Sadutshang TD, Centis R, Migliori GB. First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline. Eur Respir J. 2016 Sep;48(3):935-8.
- Tadolini M,...
Delamanid to treat MDR TB in children and adolescents
World Health Organization. The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance.
SUMMARYThe use of delamanid in the treatment of MDR-TB was recommended by the World Health Org...
Vaccine safety in pregnant women
Professor Kathryn Edwards, WAidid board members, recently authored an editorial on the NEJM commenting the work of Scheller’s group that we reported last week. Edwards underlines how the data reported are very encouraging and strongly supp...
4-valent HPV vaccine in pregnancy
This week, WAidid suggest an article on Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes, recently published on NEJM.
SUMMARY:Human papillomavirus (HPV) vaccines are recommended for all girls and women from 9 to 26 years of ag...
Drug-susceptible TB and patient care
Guidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update)
The update of the Guidelines for treatment of drug-susceptible tuberculosis and patient care is important in the context of the End TB Strategy, which recommend...
Inactivated poliovirus vaccine in Chilean infants
Professor Miguel O'Ryan, WAidid board member, suggest this week the article, funded by Bill & Melinda Gates Foundation, "Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infan...
End TB Strategy
WAidid suggests this week the article "World Health Organization. Ethics guidance for the implementation of the End TB Strategy", published in March 2017.
SUMMARY:New tuberculosis (TB) ethics guidance, launched recently by the World Health Organizat...
Guillain–Barré syndrome
The article we suggest today, "Guillain–Barré syndrome", recently published on Autoimmunity Reviews, focuses on GBS, the available therapies and the future perspectives of research in this field.
SUMMARY:Guillain–Barré synd...
Displaying 21 - 40 of 154